• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项回顾性队列研究比较了高和低球囊充气压力对慢性血液透析患者中心静脉病变治疗的技术成功率和通畅率的影响。

A retrospective cohort study comparing high and low balloon inflation pressure on technical success and patency for treating central venous lesions in patients on chronic hemodialysis.

机构信息

Department of Nephrology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China.

出版信息

Ren Fail. 2021 Dec;43(1):1281-1287. doi: 10.1080/0886022X.2021.1975741.

DOI:10.1080/0886022X.2021.1975741
PMID:34503376
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8439207/
Abstract

BACKGROUND

We aimed to analyze the success rates and the access patency rates at 12 months between patients on chronic hemodialysis with symptomatic central venous stenosis (CVS) or occlusion (CVO), receiving high or low balloon inflation pressure for treatment.

METHODS

We performed a retrospective study in which angioplasty balloons were inflated using a low-pressure or a high-pressure for the management of hemodialysis patients with CVS/CVO. The outcomes of this study were the success rate and the access patency rates at 12 months after balloon angioplasty, and the differences between groups were compared.

RESULTS

We included a total of 74 patients on hemodialysis and assigned them to the low-pressure or the high-pressure groups. Success rates in patients of the high-pressure group (94.12%) were higher than those in patients of the low-pressure group (67.50%) ( = 0.005). With a total of 59 patients with technical success, at 6 and 12 months after angioplasty, the rates of access patency in the low-pressure group were 68 and 48%, respectively; on the other hand, the primary patency rates in the high-pressure group were 86.67% (6-months) and 76.67% (12-months). The 6 and 12 months post-interventional patency rates were higher in patients of the high-pressure group than those in patients of the low-pressure group ( = 0.10 at 6 months an = 0.03 at 12 months).

CONCLUSIONS

Compared to balloon angioplasty using a low inflation pressure, hemodialysis patients with CVS/CVO receiving angioplasty using a high inflation pressure have significantly higher technical success and 12-month patency rates.

摘要

背景

我们旨在分析患有症状性中心静脉狭窄(CVS)或闭塞(CVO)的慢性血液透析患者的成功率和 12 个月时的血管通畅率,这些患者接受高或低球囊充气压力治疗。

方法

我们进行了一项回顾性研究,其中使用低压力或高压力对患有 CVS/CVO 的血液透析患者进行血管成形术球囊充气。本研究的结果是球囊血管成形术后 12 个月的成功率和血管通畅率,比较组间差异。

结果

我们共纳入 74 名血液透析患者,并将其分为低压力组或高压力组。高压力组患者的成功率(94.12%)高于低压力组患者(67.50%)( = 0.005)。在总共 59 例技术成功的患者中,在血管成形术后 6 个月和 12 个月时,低压力组的血管通畅率分别为 68%和 48%;另一方面,高压力组的主要通畅率分别为 86.67%(6 个月)和 76.67%(12 个月)。与低压力组相比,高压力组患者的 6 个月和 12 个月介入后通畅率更高( = 0.10 时为 6 个月, = 0.03 时为 12 个月)。

结论

与使用低充气压力的血管成形术相比,接受高充气压力血管成形术的患有 CVS/CVO 的血液透析患者的技术成功率和 12 个月通畅率显著更高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45f4/8439207/295c52e241f3/IRNF_A_1975741_F0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45f4/8439207/f91c9351b9ce/IRNF_A_1975741_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45f4/8439207/295c52e241f3/IRNF_A_1975741_F0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45f4/8439207/f91c9351b9ce/IRNF_A_1975741_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45f4/8439207/295c52e241f3/IRNF_A_1975741_F0002_B.jpg

相似文献

1
A retrospective cohort study comparing high and low balloon inflation pressure on technical success and patency for treating central venous lesions in patients on chronic hemodialysis.一项回顾性队列研究比较了高和低球囊充气压力对慢性血液透析患者中心静脉病变治疗的技术成功率和通畅率的影响。
Ren Fail. 2021 Dec;43(1):1281-1287. doi: 10.1080/0886022X.2021.1975741.
2
Efficacy and safety of a mother-child technique for recanalization of chronic central venous occlusive disease in hemodialysis patients.母子技术治疗血液透析患者慢性中心静脉闭塞性疾病的疗效和安全性。
J Vasc Surg Venous Lymphat Disord. 2020 Jul;8(4):558-564. doi: 10.1016/j.jvsv.2019.10.020. Epub 2019 Dec 14.
3
Long-Term Outcome of a "Mother-Child" Coaxial Dual-Catheter Technique for Percutaneous Transluminal Angioplasty of Central Vein Stenosis or Occlusion in Hemodialysis Patients.血液透析患者中心静脉狭窄或闭塞经皮腔内血管成形术“母子”同轴双导管技术的长期疗效。
J Endovasc Ther. 2024 Aug;31(4):643-650. doi: 10.1177/15266028221136434. Epub 2022 Nov 16.
4
Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients.血液透析患者中心静脉狭窄的初次血管成形术和初次支架置入术的长期预后。
J Vasc Surg. 2007 Apr;45(4):776-83. doi: 10.1016/j.jvs.2006.12.046.
5
Long-term results of stent-graft placement to treat central venous stenosis and occlusion in hemodialysis patients with arteriovenous fistulas.支架置入治疗血液透析患者动静脉瘘中心静脉狭窄和闭塞的长期结果。
J Vasc Interv Radiol. 2011 Sep;22(9):1240-5. doi: 10.1016/j.jvir.2011.06.002. Epub 2011 Jul 20.
6
Stent-Graft Length Is Associated with Decreased Patency in Treatment of Central Venous Stenosis in Hemodialysis Patients.支架移植物长度与血液透析患者中心静脉狭窄治疗中通畅率降低相关。
Ann Vasc Surg. 2019 Aug;59:225-230. doi: 10.1016/j.avsg.2019.01.024. Epub 2019 Apr 19.
7
Stent Grafts Provided Superior Primary Patency for Central Venous Stenosis Treatment in Comparison with Angioplasty and Bare Metal Stent: A Retrospective Single Center Study on 70 Hemodialysis Patients.与血管成形术和裸金属支架相比,覆膜支架在治疗中心静脉狭窄方面具有更高的初始通畅率:一项针对70例血液透析患者的回顾性单中心研究。
Vasc Endovascular Surg. 2016 May;50(4):221-30. doi: 10.1177/1538574416639149. Epub 2016 Apr 19.
8
Efficacy of covered stent placement for central venous occlusive disease in hemodialysis patients.覆膜支架置入治疗血液透析患者中心静脉闭塞性疾病的疗效。
J Vasc Surg. 2011 Sep;54(3):754-9. doi: 10.1016/j.jvs.2011.03.260. Epub 2011 Jun 12.
9
A systematic review and meta-analysis of the risk of death and patency after application of paclitaxel-coated balloons in the hemodialysis access.紫杉醇涂层球囊在血液透析通路中的应用后死亡和通畅率的系统评价和荟萃分析。
J Vasc Surg. 2020 Dec;72(6):2186-2196.e3. doi: 10.1016/j.jvs.2020.04.525. Epub 2020 Jun 12.
10
Comparison of functional patency rates between paclitaxel-eluting versus plain balloon angioplasty in hemodialysis patients with central venous stenosis: An intra-individual comparison study.紫杉醇洗脱球囊与普通球囊血管成形术治疗血液透析患者中心静脉狭窄的功能通畅率比较:一项个体内比较研究。
Ther Apher Dial. 2022 Feb;26(1):185-190. doi: 10.1111/1744-9987.13662. Epub 2021 May 8.

引用本文的文献

1
Clinical outcomes of endovascular treatment in hemodialysis patients with central venous stenosis: A retrospective analysis.血液透析患者中心静脉狭窄血管内治疗的临床结局:一项回顾性分析。
Ther Apher Dial. 2025 Jun;29(3):408-418. doi: 10.1111/1744-9987.14249. Epub 2025 Feb 3.
2
Do Balloon Catheters have a Different Radial Force Along Their Longitudinal Axis?球囊导管在其纵轴上的径向力是否不同?
Cardiovasc Intervent Radiol. 2024 Sep;47(9):1278-1285. doi: 10.1007/s00270-024-03716-x. Epub 2024 Apr 19.
3
Risk factors for blood vessel rupture during vascular access intervention therapy for hemodialysis patients.

本文引用的文献

1
Challenges and novel therapies for vascular access in haemodialysis.血液透析血管通路的挑战和新疗法。
Nat Rev Nephrol. 2020 Oct;16(10):586-602. doi: 10.1038/s41581-020-0333-2. Epub 2020 Aug 24.
2
KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update.KDIGO 临床实践指南:血管通路 2019 更新版。
Am J Kidney Dis. 2020 Apr;75(4 Suppl 2):S1-S164. doi: 10.1053/j.ajkd.2019.12.001. Epub 2020 Mar 12.
3
Comparison of Percutaneous Transluminal Angioplasty with Stenting for Treatment of Central Venous Stenosis or Occlusion in Hemodialysis Patients: A Systematic Review and Meta-analysis.
血液透析患者血管通路介入治疗中血管破裂的危险因素。
PLoS One. 2023 Mar 31;18(3):e0283844. doi: 10.1371/journal.pone.0283844. eCollection 2023.
经皮腔内血管成形术与支架置入治疗血液透析患者中心静脉狭窄或闭塞的比较:系统评价和荟萃分析。
Cardiovasc Intervent Radiol. 2020 Apr;43(4):525-540. doi: 10.1007/s00270-019-02383-7. Epub 2020 Jan 3.
4
Medial claviculectomy for the treatment of recalcitrant central venous stenosis of hemodialysis patients.锁骨内固定术治疗血液透析患者难治性中心静脉狭窄
J Vasc Surg Venous Lymphat Disord. 2019 May;7(3):420-427. doi: 10.1016/j.jvsv.2018.10.024. Epub 2019 Feb 18.
5
Central Venous Stenosis, Access Outcome and Survival in Patients undergoing Maintenance Hemodialysis.维持性血液透析患者的中心静脉狭窄、通路结局和生存。
Clin J Am Soc Nephrol. 2019 Mar 7;14(3):378-384. doi: 10.2215/CJN.07010618. Epub 2019 Feb 14.
6
Paclitaxel-Coated Balloon Angioplasty for Early Restenosis of Central Veins in Hemodialysis Patients: A Single Center Initial Experience.紫杉醇涂层球囊血管成形术治疗血液透析患者中心静脉早期再狭窄:单中心初步经验。
Korean J Radiol. 2018 May-Jun;19(3):410-416. doi: 10.3348/kjr.2018.19.3.410. Epub 2018 Apr 6.
7
Comparing the 12-month patency of low- versus high-pressure dilation in failing arteriovenous fistulae: A prospective multicenter trial (YOROI study).比较动静脉内瘘失功时低压与高压扩张的12个月通畅率:一项前瞻性多中心试验(YOROI研究)。
J Vasc Access. 2018 Sep;19(5):477-483. doi: 10.1177/1129729818760976. Epub 2018 Mar 18.
8
The pathogenesis of hemodialysis vascular access failure and systemic therapies for its prevention: Optimism unfulfilled.血液透析血管通路失败的发病机制及其预防的全身治疗:未实现的乐观。
Semin Dial. 2018 May;31(3):244-257. doi: 10.1111/sdi.12658. Epub 2017 Nov 26.
9
Paclitaxel-Coated Balloons for the Treatment of Symptomatic Central Venous Stenosis in Dialysis Access: Results from a Randomized Controlled Trial.用于治疗透析通路中症状性中心静脉狭窄的紫杉醇涂层球囊:一项随机对照试验的结果
J Vasc Interv Radiol. 2017 Jun;28(6):811-817. doi: 10.1016/j.jvir.2017.03.007. Epub 2017 Apr 20.
10
Central Venous Occlusion in the Hemodialysis Patient.血液透析患者的中心静脉阻塞。
Am J Kidney Dis. 2016 Nov;68(5):803-807. doi: 10.1053/j.ajkd.2016.05.017. Epub 2016 Aug 1.